 |
 |

Absence of Neurodegeneration and Neural Injury in the Cerebral Cortex in a Sample of Elderly Patients With Schizophrenia
Steven E. Arnold, MD;
John Q. Trojanowski, MD, PhD;
Raquel E. Gur, MD, PhD;
Peter Blackwell;
Li-Ying Han, MS;
Catherine Choi
Arch Gen Psychiatry. 1998;55:225-232.
Background The cognitive and functional deterioration that is observed in many "poor-outcome" patients with schizophrenia suggests a neurodegenerative process extending into late life. Previous diagnostic studies have excluded known neurodegenerative diseases as explanations for this dementia. However, we hypothesized that relatively small accumulations of age- or disease-related neurodegenerative lesions occurring in an otherwise abnormal brain could result in deterioration in schizophrenia.
Methods Postmortem studies were conducted using 23 prospectively accrued elderly persons with chronic schizophrenia for whom clinical ratings had been determined before death, 14 elderly control patients with no neuropsychiatric disease, and 10 control patients with Alzheimer disease. Immunohistochemistry and unbiased stereological counting methods were used to quantify common neurodegenerative lesions (ie, neurofibrillary tangles, amyloid plaques, and Lewy bodies) and cellular reactions to a variety of noxious stimuli (ubiquitinated dystrophic neurites, astrocytosis, and microglial infiltrates) in the ventromedial temporal lobe and the frontal and the calcarine (primary visual) cortices.
Results No statistically significant differences were found between the patients with schizophrenia and the control patients without neuropsychiatric disease for the densities of any of the markers, while both groups exhibited fewer lesions than did the control group with Alzheimer disease. Correlation analyses in the schizophrenia sample failed to identify significant correlations between cognitive and psychiatric ratings and densities of any of the neuropathologic markers.
Conclusions No significant evidence of neurodegeneration or ongoing neural injury in the cerebral cortex was found in this sample of elderly persons with schizophrenia. Furthermore, the behavioral and cognitive deterioration observed in late life did not correlate with age-related degenerative phenomena.
From the Departments of Psychiatry (Drs Arnold and Gur, Mr Blackwell, and Mss Han and Choi), Neurology (Drs Arnold and Gur), and Pathology and Laboratory Medicine (Dr Trojanowski), University of Pennsylvania School of Medicine, Philadelphia.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones.
Steiner et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1284-1287.
ABSTRACT
| FULL TEXT
Evidence for Oxidative DNA Damage in the Hippocampus of Elderly Patients With Chronic Schizophrenia
Nishioka and Arnold
AJGP 2004;12:167-175.
ABSTRACT
| FULL TEXT
Amyloid {beta} Pathology in Alzheimer's Disease and Schizophrenia
Religa et al.
Am. J. Psychiatry 2003;160:867-872.
ABSTRACT
| FULL TEXT
Gene Expression Profile for Schizophrenia: Discrete Neuron Transcription Patterns in the Entorhinal Cortex
Hemby et al.
Arch Gen Psychiatry 2002;59:631-640.
ABSTRACT
| FULL TEXT
Neurotoxicity, Neuroplasticity, and Magnetic Resonance Imaging Morphometry: What Is Happening in the Schizophrenic Brain?
Weinberger and McClure
Arch Gen Psychiatry 2002;59:553-558.
FULL TEXT
Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia.
Woodruff-Pak and Gould
Behav Cogn Neurosci Rev 2002;1:5-20.
ABSTRACT
Dementia as a complication of schizophrenia
de Vries et al.
J. Neurol. Neurosurg. Psychiatry 2001;70:588-596.
ABSTRACT
| FULL TEXT
Increased Neocortical Neurofibrillary Tangle Density in Subjects With Alzheimer Disease and Psychosis
Farber et al.
Arch Gen Psychiatry 2000;57:1165-1173.
ABSTRACT
| FULL TEXT
Late-Onset Schizophrenia and Very-Late-Onset Schizophrenia-Like Psychosis: An International Consensus
Howard et al.
Am. J. Psychiatry 2000;157:172-178.
ABSTRACT
| FULL TEXT
Cognitive Deficits and Psychopathology in Institutionalized versus Community-Dwelling Elderly Schizophrenia Patients
Evans et al.
J Geriatr Psychiatry Neurol 1999;12:11-15.
ABSTRACT
The neuropathology of schizophrenia: A critical review of the data and their interpretation
Harrison
Brain 1999;122:593-624.
ABSTRACT
| FULL TEXT
Protease resistant prion proteins are not present in sporadic "poor outcome" schizophrenia
Arnold et al.
J. Neurol. Neurosurg. Psychiatry 1999;66:90-92.
ABSTRACT
| FULL TEXT
Senile Degeneration and Cognitive Impairment in Chronic Schizophrenia
Dwork et al.
Am. J. Psychiatry 1998;155:1536-1543.
ABSTRACT
| FULL TEXT
|